Modular DNA Vectors for Sustained Eukaryotic Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing DNA vector systems, particularly AAV and transposon vectors, face challenges in optimizing vector components for efficient and stable gene expression in eukaryotic cells due to the large sequence space and lack of effective methods to identify beneficial combinations of regulatory elements, leading to inefficient and costly optimization processes.
Innovation Solution
Application of computational biology and data mining techniques to analyze the function of small numbers of vector elements, creating high-performing combinations of sequence elements through sequence-activity relationship modeling, and constructing optimized expression vectors for AAV and transposon vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If traditional plasmid construction methods are used, then vector assembly is simple, but gene expression stability and duration are insufficient
Solution Approach 1:
The vector is divided into functional modules: minimal AAV ITRs for packaging, transposon ends for integration, and optimized regulatory elements (promoters, enhancers, introns, terminators). Each module can be independently selected and combined to achieve stable expression while maintaining manageable construction complexity through modular assembly.
Solution Approach 2:
Computational modeling and sequence-activity relationships are established beforehand to predict which regulatory element combinations will yield stable expression. This allows pre-identification of optimal vectors before experimental construction, reducing trial-and-error complexity.
2Reliability
If all possible vector permutations are tested to optimize expression, then expression optimization is thorough, but the process is impractical due to immense sequence space
Solution Approach 1:
Sequence-activity relationships are established through computational feedback loops that analyze measured expression data and update predictive models. This allows iterative optimization of vector designs without exhaustively testing all permutations, significantly reducing time while improving reliability.
Solution Approach 2:
Instead of testing all possible sequence permutations, the invention optimizes specific critical parameters (regulatory element combinations, intron sequences, terminator variants) that have the greatest impact on expression stability. This focused parameter optimization achieves thorough optimization of key factors without the time cost of exhaustive searching.
3Ease of manufacture
If vector sequences include unnecessary elements, then vector assembly is easier, but packaging efficiency and expression stability are reduced
Solution Approach 1:
The invention extracts and removes unnecessary or detrimental sequences from traditional plasmid vectors, retaining only essential elements for stable expression: minimal AAV ITRs, transposon ends, and optimized regulatory elements. This streamlined composition improves packaging efficiency while maintaining assembly feasibility through modular design.
Solution Approach 2:
The AAV ITRs and transposon ends serve multiple functions simultaneously: they enable viral packaging, facilitate genomic integration, and provide stable maintenance in host cells. This multi-functionality reduces the need for separate unnecessary elements, simplifying vector composition while improving packaging efficiency.
Data Source
AI summary
The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel elements that further improve expression. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.